Robert S Kopriva Net Worth

What's Robert Kopriva's mailing address?

Robert's mailing address filed with the SEC is 6720 N. SCOTTSDALE RD, SUITE 390, SCOTTSDALE, AZ, 85253.

Insiders trading at RiceBran Technologies

Over the last 12 years, insiders at RiceBran Technologies have traded over $4,078,827 worth of RiceBran Technologies stock and bought 7,837,541 units worth $14,259,016 . The most active insiders traders include Grain Co Continental, Brent D Rosenthal a Brent Robert Rystrom. On average, RiceBran Technologies executives and independent directors trade stock every 33 days with the average trade being worth of $15,329. The most recent stock trade was executed by Grain Co Continental on 23 May 2022, trading 1,797,000 units of RIBT stock currently worth $1,293,840.

What does RiceBran Technologies do?

ricebran technologies (nasdaq: ribt) is unlocking the value of rice bran, an underutilized, renewable and sustainable by-product of the international rice milling industry. using our proprietary and patented technologies to stabilize and further process rice bran, we are able to produce nutrient dense, sustainably sourced rice bran ingredients that increase the nutritional value of foods and beverages. ricebran technologies’ products are non-gmo, vegetarian, vegan, and gluten free. our company has the potential to satisfy a significant portion of the increasing global demand for protein, dietary fiber, edible oil and other human food ingredients, as well as produce finished functional foods and rice bran based nutricosmetics. our technology captures the value of rice bran without increasing the use of arable land or water. ricebran technologies’ target markets include manufacturers and retailers for human food ingredients, packaged functional foods, nutraceuticals, personal care produc

RiceBran Technologies executives and stock owners

RiceBran Technologies executives and other stock owners filed with the SEC include:

• Todd Mitchell,
  Chief Financial Officer, Secretary
• Todd Travis Mitchell,
  CFO & Sec.
• Brent Rosenthal,
  Lead Independent Director
• Peter G. Bradley,
  Exec. Chairman & Acting Principal Exec. Officer
• Richard Galterio,
  IR Contact Officer
• David Chemerow,
  Independent Director
• Beth Bronner,
  Independent Director
• Ari Gendason,
  Independent Non-Executive Vice Chairman of the Board
• Peter Bradley,
  Executive Chairman of the Board
• Dr. Joseph Gutman M.D.,
  Strategic Consultant & Member of Medical Advisory Board
• Eric Tompkins,
  Sr. VP of Bus. Devel.
• Sherry Rhoads,
  VP of Compliance, Regulatory & External Affairs
• Dr. Rani Madhavapeddi Patel,
  Chief Science Officer
• Connie Kelly,
  Chief Accounting Officer
• Robert DePaul,
  VP of Operations
• Dale Belt,
  CFO & Secretary
• Robert D Smith,
  Senior VP of Sales and BD
• David Goldman,
  
• Baruch Halpern,
  
• W. John Short,
  CEO
• Henk Hoogenkamp,
  Director
• William J Keneally,
  Interim CFO
• Michael Goose,
  President of USA Ingredients
• Robert S Bucklin,
  Director
• Grain Co Continental,
  10% owner
• Dennis Dykes,
  CFO and EVP
• Peter A Woog,
  Director
• Robert S Kopriva,
  Director
• Marco V Galante,
  Director
• Robert C Schweitzer,
  Director
• Colin Garner,
  Sr. Vice President Sales
• James C Lintzenich,
  
• Richard Koppes,
  Director
• Edward Mcmillan,
  
• Mark S Mc Knight,
  
• Jean Heggie,
  Director
• William Black,
  Director
• Brent Robert Rystrom,
  CEO & President